163 related articles for article (PubMed ID: 16586119)
21. Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy.
Winston A; Duncombe C; Li PC; Gill JM; Kerr SJ; Puls RL; Taylor-Robinson SD; Emery S; Cooper DA;
Neuroradiology; 2012 Dec; 54(12):1331-9. PubMed ID: 22772471
[TBL] [Abstract][Full Text] [Related]
22. Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review.
Baruth JM; Wall CA; Patterson MC; Port JD
Autism Res; 2013 Apr; 6(2):119-33. PubMed ID: 23436782
[TBL] [Abstract][Full Text] [Related]
23. A repeat proton magnetic resonance spectroscopy study in social phobia.
Tupler LA; Davidson JR; Smith RD; Lazeyras F; Charles HC; Krishnan KR
Biol Psychiatry; 1997 Sep; 42(6):419-24. PubMed ID: 9285077
[TBL] [Abstract][Full Text] [Related]
24. [Cerebral metabolic disturbance in hypoxic encephalopathy: evaluation with H-1 MR spectroscopy].
Suzuki S; Ichijo M; Fujii H; Ikeda K; Hitosugi M
Rinsho Shinkeigaku; 1996 Jul; 36(7):844-9. PubMed ID: 8952350
[TBL] [Abstract][Full Text] [Related]
25. White matter NAA/Cho and Cho/Cr ratios at MR spectroscopy are predictive of motor outcome in preterm infants.
Kendall GS; Melbourne A; Johnson S; Price D; Bainbridge A; Gunny R; Huertas-Ceballos A; Cady EB; Ourselin S; Marlow N; Robertson NJ
Radiology; 2014 Apr; 271(1):230-8. PubMed ID: 24475798
[TBL] [Abstract][Full Text] [Related]
26. Application of
Wang J; Zhou T; Liu J; Shangguan J; Liu X; Li Z; Zhou X; Ren Y; Wang C
BMC Nephrol; 2020 Jun; 21(1):225. PubMed ID: 32539705
[TBL] [Abstract][Full Text] [Related]
27. Proton magnetic resonance spectroscopic findings of cerebral fat embolism induced by triolein emulsion in cats.
Baik SK; Kim YW; Kim HJ; Lee JW; Cho BM; Kim DH; Choi SH; Lee SH; Chang KH
Acta Radiol; 2008 Dec; 49(10):1174-81. PubMed ID: 19031181
[TBL] [Abstract][Full Text] [Related]
28. In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease.
Pfefferbaum A; Adalsteinsson E; Spielman D; Sullivan EV; Lim KO
Arch Gen Psychiatry; 1999 Feb; 56(2):185-92. PubMed ID: 10025444
[TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance spectroscopy features of normal-appearing white matter in patients with acute brucellosis.
Kayabas U; Alkan A; Firat AK; Karakas HM; Bayindir Y; Yetkin F
Eur J Radiol; 2008 Mar; 65(3):417-20. PubMed ID: 17920223
[TBL] [Abstract][Full Text] [Related]
30. Decreased choline and creatine concentrations in centrum semiovale in patients with generalized anxiety disorder: relationship to IQ and early trauma.
Coplan JD; Mathew SJ; Mao X; Smith EL; Hof PR; Coplan PM; Rosenblum LA; Gorman JM; Shungu DC
Psychiatry Res; 2006 Jun; 147(1):27-39. PubMed ID: 16797939
[TBL] [Abstract][Full Text] [Related]
31. Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy.
Ajilore O; Haroon E; Kumaran S; Darwin C; Binesh N; Mintz J; Miller J; Thomas MA; Kumar A
Neuropsychopharmacology; 2007 Jun; 32(6):1224-31. PubMed ID: 17180124
[TBL] [Abstract][Full Text] [Related]
32. Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy.
Bokemeyer M; Ding XQ; Goldbecker A; Raab P; Heeren M; Arvanitis D; Tillmann HL; Lanfermann H; Weissenborn K
Gut; 2011 Mar; 60(3):370-7. PubMed ID: 20926642
[TBL] [Abstract][Full Text] [Related]
33. Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia.
Yamasue H; Fukui T; Fukuda R; Kasai K; Iwanami A; Kato N; Kato T
Int J Neuropsychopharmacol; 2003 Dec; 6(4):353-60. PubMed ID: 14604450
[TBL] [Abstract][Full Text] [Related]
34. Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis.
Inglese M; Li BS; Rusinek H; Babb JS; Grossman RI; Gonen O
Magn Reson Med; 2003 Jul; 50(1):190-5. PubMed ID: 12815694
[TBL] [Abstract][Full Text] [Related]
35. Detection of metabolites in the white matter of frontal lobes and hippocampus with proton in first-episode treatment-naïve schizophrenia patients.
He ZL; Deng W; Li ML; Chen ZF; Collier DA; Ma X; Li T
Early Interv Psychiatry; 2012 May; 6(2):166-75. PubMed ID: 21951785
[TBL] [Abstract][Full Text] [Related]
36. Effect of 12-week administration of 20-mg long-acting methylphenidate on Glu/Cr, NAA/Cr, Cho/Cr, and mI/Cr ratios in the prefrontal cortices of school-age children in Indonesia: a study using 1H magnetic resonance spectroscopy (MRS).
Wiguna T; Guerrero AP; Wibisono S; Sastroasmoro S
Clin Neuropharmacol; 2012; 35(2):81-5. PubMed ID: 22318191
[TBL] [Abstract][Full Text] [Related]
37. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
Chen CS; Chiang IC; Li CW; Lin WC; Lu CY; Hsieh TJ; Liu GC; Lin HF; Kuo YT
Psychiatry Res; 2009 Jun; 172(3):210-4. PubMed ID: 19303260
[TBL] [Abstract][Full Text] [Related]
38. Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy.
Metastasio A; Rinaldi P; Tarducci R; Mariani E; Feliziani FT; Cherubini A; Pelliccioli GP; Gobbi G; Senin U; Mecocci P
Neurobiol Aging; 2006 Jul; 27(7):926-32. PubMed ID: 15936850
[TBL] [Abstract][Full Text] [Related]
39. Proton MR spectroscopic study at 3 Tesla on glutamate/glutamine in Alzheimer's disease.
Hattori N; Abe K; Sakoda S; Sawada T
Neuroreport; 2002 Jan; 13(1):183-6. PubMed ID: 11924885
[TBL] [Abstract][Full Text] [Related]
40. Cerebral metabolic abnormalities in COPD patients detected by localized proton magnetic resonance spectroscopy.
Shim TS; Lee JH; Kim SY; Lim TH; Kim SJ; Kim DS; Kim WD
Chest; 2001 Nov; 120(5):1506-13. PubMed ID: 11713127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
